Welcome to Episode #40 of Bills & Business. In this episode, Laura Carr, Co-Founder of USLege, sits down with Amy Whited, Regional Director of Government Affairs at Genmab, a global biotechnology company pioneering antibody-based therapeutics to fight cancer.Amy’s story spans more than two decades in politics and advocacy, from campaign war rooms to the forefront of biotech innovation. She shares her journey from political strategist to corporate advocate, offering a unique lens into how science, policy, and patient outcomes intersect.Together, Laura and Amy discuss how Genmab is advancing research in gynecologic cancers, addressing disparities in women’s health, and influencing public policy both in Texas and across the Western states. The conversation also explores the business side of health innovation. How advocacy can drive economic impact while shaping more humane and effective treatments.Don’t forget to subscribe to Bills & Business on Apple Podcasts, Spotify, and YouTube for more deep dives into Texas policy and business news.

📲 Follow Laura Carr
🐦 Twitter: @Laura_USLege
💼 LinkedIn: @Laura Carr
📸 Instagram: @thereallauracarr
🛍️ ShopMy: @lauraluise
✍️ Substack: @lauraluise
🔗 Links: @lauraluise

📲 Follow USLege
✨ Instagram: @uslege.ai
📘 Facebook: @uslege.ai
🐦 Twitter: @USLege_ai
💼 LinkedIn: @USLege

🎧 Subscribe to Bills & Business
▶️ YouTube: @BillsandBusiness
🎵 Spotify: Bills and Business by USLege
🍎 Apple Podcasts: Bills and Business by USLege
🎥 TikTok: @billsandbusiness

📲 Follow Amy Whited
💼 LinkedIn: @Amy Whited
🐦 Twitter: @amy_whited

🎬 Produced by USLege
📞 Want to see USLege in action? Schedule a demo today!